ArticlePloS one2015

Differential cardiovascular outcomes after dipeptidyl peptidase-4 inhibitor, sulfonylurea, and pioglitazone therapy, all in combination with metformin, for type 2 diabetes: a population-based cohort study.

Jong-Mi Seong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.